Your browser doesn't support javascript.
loading
Programmed cell death-1 receptor-mediated regulation of Tbet+NK1.1- innate lymphoid cells within the tumor microenvironment.
Lim, Jing Xuan; Lai, Chester Y; Mallett, Grace E; McDonald, David; Hulme, Gillian; Laba, Stephanie; Shapanis, Andrew; Payne, Megan; Patterson, Warren; Alexander, Michael; Coxhead, Jonathan; Filby, Andrew; Plummer, Ruth; Lovat, Penny E; Sciume, Giuseppe; Healy, Eugene; Amarnath, Shoba.
Afiliación
  • Lim JX; Newcastle University Biosciences Institute, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
  • Lai CY; Newcastle University Centre for Cancer, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
  • Mallett GE; Dermatopharmacology, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom.
  • McDonald D; Dermatology, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, United Kingdom.
  • Hulme G; Newcastle University Biosciences Institute, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
  • Laba S; Newcastle University Centre for Cancer, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
  • Shapanis A; Newcastle University Biosciences Institute, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
  • Payne M; Newcastle University Biosciences Institute, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
  • Patterson W; Newcastle University Biosciences Institute, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
  • Alexander M; Dermatopharmacology, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom.
  • Coxhead J; Newcastle University Biosciences Institute, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
  • Filby A; Newcastle University Biosciences Institute, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
  • Plummer R; Newcastle University Centre for Cancer, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
  • Lovat PE; Newcastle University Biosciences Institute, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
  • Sciume G; Newcastle University Biosciences Institute, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
  • Healy E; Newcastle University Biosciences Institute, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
  • Amarnath S; Newcastle University Translational and Clinical Research Institute, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
Proc Natl Acad Sci U S A ; 120(18): e2216587120, 2023 05 02.
Article en En | MEDLINE | ID: mdl-37098069
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos / Neoplasias Límite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos / Neoplasias Límite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido